Pioneering FIP Treatment helps save over 250 cats from previously considered untreatable disease.
Austin, TX – [Date] – Austin Pets Alive! (APA!) has been working with the University of Florida Shelter Medicine program to conduct research on an innovative treatment to save cats infected with Feline Infectious Peritonitis (FIP). Until recently, there were no viable or publicly available treatments for the disease, but the medication is now available to the public, providing hope for shelter cats. In July, more information was published on the findings for treatment strategies, diagnoses, and findings.
Feline Infectious Peritonitis (FIP), which most commonly affects cats under 3 years old and has increased risk in purebreds and shelters, has long been feared as one of the most deadly and untreatable diseases in cats. APA! has been at the forefront of treatment research, working closely with leading veterinarians and scientists to develop and refine this life-saving protocol.
“We are incredibly proud of the role APA! has played in bringing this treatment to fruition,” said Alexis Bardzinski DVM, Medical Director at Austin Pets Alive!. “Our mission has always been to save as many lives as possible, especially the most vulnerable populations of pets. This breakthrough treatment is a testament to the power of collaboration and innovation in the field of animal welfare.”
Austin Pets Alive! was among the very first to begin treating shelter cats for FIP. The nonprofit also hosts one of the largest adoption programs for cats with Feline Leukemia Virus (FeLV). The shelter has an ongoing collaboration with the research team at the Shelter Medicine Program at the University of Florida to compare the response to FIP treatment in shelter cats with and without FeLV co-infection.
The treatment is now accessible to veterinarians and shelters across the country, offering a new standard of care for animals in need.
For more information about the treatment and how it can benefit your pet or shelter, please email the FIP team at [email protected] for further information or questions about their treatment process.
To request and interview or for additional information, please email [email protected].
